Fact sheet: Wellington GlHthcrEq

Fund information

Fund name
Wellington Global Health Care Equity D Unhedged Acc USD
Fund company manager
Wellington Management Funds
Fund type
SIB
Fund manager
Ann C Gallo
since 01/01/2013
Fund objective
The Wellington Global Health Care Equity Fund seeks long-term total returns. The Investment Manager will actively manage the Fund, seeking to achieve the objective by investing in the equity securities of health care companies worldwide. The Fund takes a long term value approach and seeks to invest in fundamentally sound companies. Although the Fund is not constructed relative to a benchmark, the MSCI World Health Care index will serve as a reference benchmark.
Benchmark
No Specified Index
Investment style
None
Investment method
Shares

Quick stats

1 Year return

11.99 %

1 Year rank in sector

8/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.8 b

FE Risk score

157

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    82.5%
  • Europe
    9.4%
  • Japan
    4.9%
  • Global Emerging Markets
    2.3%
  • Asia Pacific ex Japan
    0.5%
  • Biotechnology/Medical
    76.6%
  • Health Care
    23.4%
  • North American Equities
    82.5%
  • European Equities
    9.4%
  • Japanese Equities
    4.9%
  • Global Emerging Market Equities
    2.3%
  • Asia Pacific ex Japan Equities
    0.5%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund2.55 %8.04 %10.6 %38.42 %130.66 %
Sector2.66 %5.85 %6.87 %21.25 %96.31 %
Rank within sector17 / 3013 / 308 / 296 / 273 / 23
Quartile th3 rd2 nd2 nd1 st1 st

Calendar performance

YTD-20172016201520142013
Fund20.58 %-10.03 %14.62 %27.71 %48.26 %
Sector15.39 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector9 / 2915 / 296 / 2715 / 249 / 23
Quartile th2 nd3 rd1 st3 rd2 nd

Risk statistics

Alpha3.94
Beta1.02
Sharpe0.48
Volatility16.66
Tracking error5.48
Information ratio0.72
R-Squared0.89

Price movement

52 week high32.81
52 week low24.96
Current bid price0
Current offer price0
Current mid price31.808

Holdings by region

  • 82.5% North America
  • 9.4% Europe
  • 4.9% Japan
  • 2.3% Global Emerging Markets
  • 0.5% Asia Pacific ex Japan
  • 0.4% Middle East

Holdings by sector

  • 76.6% Biotechnology/Medical
  • 23.4% Health Care

Holdings by asset type

  • 82.5% North American Equities
  • 9.4% European Equities
  • 4.9% Japanese Equities
  • 2.3% Global Emerging Market Equities
  • 0.5% Asia Pacific ex Japan Equities
  • 0.4% Middle East & African Equities

Individual holdings

  • 4.3% UNITEDHEALTH GROUP INC
  • 3.9% BRISTOL MYERS SQUIBB SA
  • 3.5% ALLERGAN PLC
  • 3.3% PORTOLA PHARMACEUTICALS INC
  • 2.8% ASTRAZENECA PLC
  • 2.8% BOSTON SCIENTIFIC CORP
  • 2.4% ALKERMES PLC
  • 2.1% ALNYLAM PHARMACEUTICALS INC
  • 2.1% LILLY (ELI) & CO
  • 2.1% MEDTRONIC INC